A TRIPS waiver is urgently needed to make progress on COVID-19 vaccine equity
The coalition's Social Science Working Group and co-signatories have published a viewpoint on vaccine equity, arguing that a temporary TRIPS waiver is needed for COVID-19 vaccines and other medicines. Vaccine inequity is amongst the most significant social justice issues of our generation, and it poses a major threat to the global COVID-19 response. Urgent action is needed to improve equity and bring an end to the COVID-19 pandemic, including in low- and middle-income countries.
INTERVIEW I Dr Brenda Okware on CBC Radio
Dr Brenda Okware, Scientific Coordinator of the COVID-19 Clinical Research Coalition, was recently featured on Canada's Most Listened-to Radio Program, The Current hosted by Matt Galloway on CBC Radio. She discussed recent COVID-19 developments in Uganda as well as equitable access to vaccines in low- and middle-income countries.
Finding treatments for COVID-19: Phase 2 study seeks partner sites
PLATCOV is a phase 2 platform study assessing antivirals in early COVID-19 disease. It is looking for sites to be able to rapidly set up and recruit into this platform trial within 4 months, for an 18 month period. The study is run out of the Mahidol Oxford Tropical Medicine Research Unit in Bangkok, Thailand, led by Professor Sir Nicholas White and sponsored by the University of Oxford. The study has funding and is ready to begin.
COVID-19 research priorities in maternal, reproductive, and child health
The coalition’s Maternal, Newborn, and Child Health Working Group conducted a research priority-setting exercise to identify global research priorities in maternal, reproductive and child health. Members of the working group shared the results in this webinar.